Sign in Create account

Artemis Medicare Services Limited

Healthcare · Healthcare Services

NSE: ARTEMISMED BSE: 542919
₹345.55
▼ -21.05 (-5.74%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
67/100
Moderate
Valuation
24/100
Expensive
Momentum
85/100
Bullish

QVM read Momentum-led Quality Moderate, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹5,470 Cr
PE (TTM)
48.3
Industry median 50.2 (44 companies)
Price to Book
5.8
PEG (TTM)
1.8
Institutions holding %
14.69%
FII + DII, latest filed period
Piotroski Score
7
Relative return vs Nifty50, qtr %
41.1
Relative return vs Sector, qtr %
34.4
Free Cash Flow
₹27 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
44.12%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
38.45%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
15.49%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
44.98%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
12.89%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.74
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.24
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
6.74
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
11.01%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
17.21%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
16.20%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
7.26%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
13.70%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
11.03%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 7)
  • Yes Debt to equity is below 0.5 (0.24)
  • No Return on equity is 15% or more (11.0%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.7%
Low 342.1000 · High 370.1000
1W return
1.1%
Low 331.1000 · High 378.8000
1M return
8.9%
Low 306.6000 · High 378.8000
52W return
47.2%
Low 203.3500 · High 378.8000
Lifetime High ₹412.8000 (Sept. 22, 2021)
Lifetime Low ₹32.1500 (Oct. 20, 2021)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish4
Bearish2
5D
352.8
10D
348.4
20D
341.2
50D
322.9
100D
302.2
200D
269.4

Delivery and volume

Day avg. delivery
49.2%
Week avg. delivery
14.6%
Month avg. delivery
22.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

352.58
Pivot
First resistance363.07
Second resistance380.58
Third resistance391.07
First support335.07
Second support324.58
Third support307.07
Day RSI54.6
Day MFI90.4
Day MACD9.52
Day MACD signal8.76

Beta

1M1.41
3M1.49
1Y0.84
3Y0.88

Price change analysis

↑ 8.9%
Over 1 Month
LowHigh
306.60378.80
↑ 31.6%
Over 3 Months
LowHigh
258.40378.80
↑ 55.3%
Over 6 Months
LowHigh
215.02378.80
↑ 47.2%
Over 1 Year
LowHigh
203.35378.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 48.3 (own history: 31.4–63.6)
Fair Value Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹282 Cr
Net profit (June 30, 2026)
₹31 Cr
Basic EPS (June 30, 2026)
₹1.9600

Ranks #22 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter58.39%
  • Mutual funds1.30%
  • FII/FPI12.29%
  • Other DII1.10%
  • Public26.92%

Largest holders

NameCategoryShares %Shares
Constructive Finance Private LimitedPromoter58.3800%92425790
INTERNATIONAL FINANCE CORPORATIONPublic11.9800%18962247
GOVERNOR OF KERALAPublic4.2600%6749600
DEVLINA CHAKRAVARTYPublic2.9200%4628520
KERALA STATE INDUSTRIAL DEVELOPMENT CORPORATIONPublic1.9000%3000000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 58.39% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 12.19% to 12.29% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 1.69% to 1.30% in Jun 2026 qtr

8 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 6 insider trades, 4 SAST, 1 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
23 Jun 2021 Prem Narain Wahal Other Buy 0 ₹0
23 Jun 2021 Neeru Wahal Immediate relative Buy 0 ₹0
22 Jun 2021 Prem Narain Wahal Other Buy 0 ₹0
22 Jun 2021 Neeru Wahal Immediate relative Buy 0 ₹0
22 Jun 2021 Neeru Wahal Immediate relative Buy 0 ₹0
22 Jun 2021 Prem Narain Wahal Other Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 4 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
25 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 1,004,061 366.1500 NSE
25 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 1,004,061 365.8000 NSE
25 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 1,004,061 366.1500 NSE
25 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 1,004,061 365.8000 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
3 Aug 2026 Financial Results Yes
4 Jun 2026 Other business matters —
8 May 2026 Financial Results Yes
2 Feb 2026 Financial Results/Fund Raising Yes
11 Nov 2025 Financial Results Yes

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Company Update Artemis Medicare Services Ltd - 542919 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
29 Sep 2026 Company Update Artemis Medicare Services Ltd - 542919 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
28 Sep 2026 Insider Trading / SAST Artemis Medicare Services Ltd - 542919 - Closure of Trading Window
15 Sep 2026 Company Update Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Sep 2026 Company Update Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.24)
  • Healthy liquidity (Current Ratio 1.74)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (48.3) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Artemis Medicare Services Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.